赛升药业股价微涨0.49% 中报净利润4778万元实现扭亏

Group 1 - The latest stock price of Sai Sheng Pharmaceutical is 14.26 yuan, up 0.49% from the previous trading day, with a highest intraday price of 14.34 yuan and a lowest of 14.17 yuan, and a trading volume of 120,780 hands, amounting to 172 million yuan [1] - The company operates in the biopharmaceutical industry, focusing on the research, production, and sales of biological drugs [1] - For the first half of 2025, the company reported total operating revenue of 197 million yuan and a net profit attributable to shareholders of 47.78 million yuan, achieving a turnaround from loss to profit compared to the same period last year [1] - The company's gross profit margin stands at 64.78%, and its asset-liability ratio is maintained at a low level of 4.65% [1] - The latest report indicates that Sai Sheng Pharmaceutical had a net cash inflow from operating activities of 29.34 million yuan for the first half of 2025 [1] - As of August 21, 2025, there are 6 institutional investors holding shares in the company, with a total holding ratio of 1.85%, an increase of 0.86 percentage points from the previous quarter [1] Group 2 - In terms of capital flow, the company experienced a net outflow of 13.98 million yuan from main funds on the day, with a cumulative net outflow of 51.28 million yuan over the past five days [2]